Status:
COMPLETED
A Feasibility Study of an AI-Powered Clinical Decision Aid for Personalized Depression Treatment Selection
Lead Sponsor:
Aifred Health Inc.
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Clinical Decision Aid (CDA) is a predictive model that takes as input individual patient characteristics, called 'features', which are inputted by the physician or by patient self-report, and outp...
Detailed Description
Hypothesis 1. There will not be a significant difference in measured non-initial intake appointment lengths between the baseline period and the appointment length measured at two and four months after...
Eligibility Criteria
Inclusion
- All patients of the physicians in the study are diagnosed with major depressive disorder by a physician using DSM-V criteria.
- All participants must be able to provide informed consent.
- Contraception will be used as per established clinical guidelines and usual clinical practice for medications known to cause birth defects. The medications prescribed and the use of and type of contraception will be determined by the physicians in the study in consultation with their patients as would usually occur in clinical practice.
Exclusion
- Bipolar disorder type 1 or 2, as the data we have used to train the model does not allow for generalization to bipolar disorder (either pre-existing or as diagnosed according to DSM-5 criteria).
- Inability or unwillingness of individual to give informed consent.
Key Trial Info
Start Date :
December 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04061642
Start Date
December 16 2019
End Date
December 31 2020
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Douglas Mental Health University Institute
Verdun, Quebec, Canada, H4H 1R3